Cancers, Vol. 15, Pages 4409: An Overview of Head and Neck Tumor Reirradiation: What Has Been Achieved So Far?

Cancers, Vol. 15, Pages 4409: An Overview of Head and Neck Tumor Reirradiation: What Has Been Achieved So Far?

Cancers doi: 10.3390/cancers15174409

Authors: Konstantin Gordon Daniil Smyk Igor Gulidov Kirill Golubev Timur Fatkhudinov

The recurrence rate of head and neck cancers (HNCs) after initial treatment may reach 70%, and poor prognosis is reported in most cases. Curative options for recurrent HNCs mainly depend on the treatment history and the recurrent tumor localization. Reirradiation for HNCs is effective and has been included in most guidelines. However, the option remains clinically challenging due to high incidence of severe toxicity, especially in cases of quick infield recurrence. Recent technical advances in radiation therapy (RT) provide the means for upgrade in reirradiation protocols. While the majority of hospitals stay focused on conventional and widely accessible modulated RTs, the particle therapy options emerge as tolerable and providing further treatment opportunities for recurrent HNCs. Still, the progress is impeded by high heterogeneity of the data and the lack of large-scale prospective studies. This review aimed to summarize the outcomes of reirradiation for HNCs in the clinical perspective.